Zurueck zur Suche

Reporte zur Charge U022175

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

15Reporte angezeigt
0Todesfaelle
1Hospitalisiert
1Lebensbedrohlich
0Bleibende Schaeden
MO 3 NY 2 AZ 1 CA 1 FL 1 NC 1 SC 1 IL 1 CT 1 TX 1 GA 1 MI 1

VAERS 2519012

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U022175

kritisch
Staat
AZ
Alter
1,0
Geschlecht
M
Eingang
29.11.2022
Impfdatum
23.11.2022
Beginn
23.11.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
SC / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Adenovirus test Alanine aminotransferase Alcohol test Amylase Anion gap Aspartate aminotransferase Bilirubin conjugated Blood albumin Blood alkaline phosphatase Blood bilirubin Blood calcium increased Blood chloride increased Blood cholesterol Blood creatine phosphokinase Blood creatinine decreased Blood glucose normal Blood lactate dehydrogenase Blood magnesium

Symptomtext

Patient after third vaccine and then immediately had arrest of respiration with cyanosis and limpness of all 4 extremities with eyes rolling back. After about 3 minutes started crying and seemed sleepy. Was transferred from peds clinic to ER for further workup.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Respiratory arrest
Hospital-Tage
-
Labordaten
---- Chemistry - enGen ---- SERUM 11/23 Reference 2022 17:00 Units Ranges ------------------------------------------------------------------------------- GLUCOSE 127 H mg/dL 70 - 110 BUN 12 mg/dL 7 - 20 CREAT 0.3 L mg/dL 0.8 - 1.3 NA 140 mmol/L 137 - 145 K 4.2 mmol/L 3.6 - 5.2 CL 108 mmol/L 100 - 108 CO2 18 L mmol/L 21 - 32 AN GAP 14.8 H mmol/L 4.0 - 12.0 CALCIUM 10.7 H mg/dL 8.8 - 10.5 PROTEIN g/dL 6.4 - 8.2 ALBUMIN g/dL 3.4 - 5 ALK PHO U/L 50 - 136 AST U/L 27 - 47 SGPT U/L 0 - 50 T BILI mg/dL .1 - 1 D BILI mg/dL 0 - .3 EST GFR mL.min/1.73m2Ref: >=60 PO4 mg/dL 2.5 - 4.9 MG mg/dL 1.8 - 2.4 URIC AC mg/dL 3.5 - 7.2 AMYLASE U/L 30 - 115 LIPA U/L 23 - 300 CK U/L 35 - 232 LDH(VR) U/L 313 - 618 CRP-V mg/dL Ref: <=1 ETOH mg/dL Ref: <10 SPACER CHOL mg/dL 0 - 200 TRIGLYC mg/dL 30 - 200 dHDL mg/dL Ref: >35 OLD LDL mg/dL 0 - 130 CHL/HDL d-LDL mg/dL 0 - 100 Comments: a a. Evaluation for GLUCOSE: FASTING BLOOD GLUCOSE LEVELS BETWEEN 100 - 125 mg/dL is consistent with Pre-diabetes. FBG > 126 mg/dL is consistent with DIABETES. Inserted guideline on 4/25/07. ---- MISCELLANEOUS TESTS ---- DATE TIME SPECIMEN TEST VALUE Ref ranges ------------------------------------------------------------------------------- 11/23/2022 17:00 SERUM _GFR: N/A mL.min/1.73m2Ref: >=60 11/23/2022 17:00 NASOPHARYNGEAL M ADENOVIRUS: Negative Ref: Negative 11/23/2022 17:00 NASOPHARYNGEAL M CoV-229E: Negative Ref: Negative 11/23/2022 17:00 NASOPHARYNGEAL M CoV-HKU1: Negative Ref: Negative 11/23/2022 17:00 NASOPHARYNGEAL M CoV-NL63: Negative Ref: Negative 11/23/2022 17:00 NASOPHARYNGEAL M CoV-OC43: Negative Ref: Negative 11/23/2022 17:00 NASOPHARYNGEAL M SARS CoV-2: POSITIVE Ref: Negative 11/23/2022 17:00 NASOPHARYNGEAL M HUMAN METAPNEUMO:Negative Ref: Negative 11/23/2022 17:00 NASOPHARYNGEAL M RHINO/ENTEROV:Negative Ref: Negative 11/23/2022 17:00 NASOPHARYNGEAL M INFLU B: Negative Ref: Negative 11/23/2022 17:00 NASOPHARYNGEAL M PARAINFLU 1: Negative Ref: Negative 11/23/2022 17:00 NASOPHARYNGEAL M PARAINFLU 2: Negative Ref: Negative 11/23/2022 17:00 NASOPHARYNGEAL M PARAINFLU 3: Negative Ref: Negative 11/23/2022 17:00 NASOPHARYNGEAL M PARAINFLU 4: Negative Ref: Negative 11/23/2022 17:00 NASOPHARYNGEAL M RSV BF: Negative Ref: Negative 11/23/2022 17:00 NASOPHARYNGEAL M B PPERT (IS1001):Negative Ref: Negative 11/23/2022 17:00 NASOPHARYNGEAL M B PERT (ptxP):Negative Ref: Negative 11/23/2022 17:00 NASOPHARYNGEAL M CHL PNEUMO: Negative Ref: Negative 11/23/2022 17:00 NASOPHARYNGEAL M MYCO PNEUMO: Negative Ref: Negative 11/23/2022 17:00 NASOPHARYNGEAL M _Influenza A:Negative Ref: Negative Evaluation for MYCO PNEUMO: Testing performed by Real-Time PCR. 11/03/2022 13:10 NASOPHARYNGEAL M RSV TMC: NEGATIVE Ref: Negative 11/03/2022 13:10 NASOPHARYNGEAL M GENE XPERT COV19:POSITIVE Ref: Negative 11/03/2022 13:10 NASOPHARYNGEAL M FLU A PCR PLUS:NEGATIVE Ref: Negative 11/03/2022 13:10 NASOPHARYNGEAL M FLU B PCR PLUS:NEGATIVE Ref: Negative Evaluation for RSV:
Aktuelle Erkrankungen
Covid + 11/3 and 11/23
Vorgeschichte
History of cleft lip and palate repair, failure to thrive
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 2504528

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U022175

schwer
Staat
MO
Alter
18,0
Geschlecht
M
Eingang
10.11.2022
Impfdatum
31.05.2022
Beginn
01.06.2022
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Chest pain Dyspnoea exertional Electrocardiogram Fatigue Immunoglobulin therapy Laboratory test Myopericarditis Pericarditis Troponin increased Vomiting

Symptomtext

He just reported to basic training on 5/23/22 and was given the vaccines on 5/31/22. Mother is reporting this. As far as she knows is that he started having some chest pain with vomiting and then the vomiting stopped, the chest pain got worse and worse on activity like running and exercise. Right after he got the vaccines then they went into actual training. Then he started having the symptoms and he reported them to the Supervisor who then sent him over to the clinic. Then they did an EKG and other tests and then he was transported by ambulance to the ER. Then he was admitted with pericarditis. After being admitted then he was diagnosed with myo-pericarditis and was there from 6/2/22 to 6/10/22. Mothers understanding is that he was given steroids, IV fluids, some other medicines such as Colchicine, Solumedrol and 5 treatments with the immunoglobulins. Eventually they started treating him with immunoglobulins, and then once they did that his troponin's started going down as they were elevated. Then he was discharged he went back to the base which the cardiologist put him on no strenuous activity for 6 moths. He continues to have the chest pains. They are doing a med-board process at this time but he cannot stay in the employment unless he is cleared by the cardiologist, and they are still having him with symptoms and is not going to clear him to stay. He is due to have a cardiac stress test to determine if he can stay or not. When he was discharged he was taking a steroid and Ibuprofen but that was discontinued within a couple of weeks. He has not been treated with anything else for his symptoms. Mother states that he says that he is very fatigued and depending on what he is doing activity wise he has the chest pains and shortness of breath. He is being treated at the Facility while on location.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Myopericarditis
Hospital-Tage
8,0
Labordaten
Multiple in the hospital.
Aktuelle Erkrankungen
None.
Vorgeschichte
None.
Andere Medikamente
None.
Allergien
Amoxicillin.
Vorherige Impfungen
-

VAERS 2388531

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U022175

schwer
Staat
CA
Alter
12,0
Geschlecht
F
Eingang
25.07.2022
Impfdatum
25.07.2022
Beginn
25.07.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
SC / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Blood pressure measurement Loss of consciousness Syncope

Symptomtext

Patient had a syncope episode about 10 minutes after receiving vaccines, patient was unconscious less than 1 minute and was able to tell us her name and were she was.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Loss of consciousness
Hospital-Tage
-
Labordaten
Patient was monitored by physician and staff, blood pressure was taken, given juice to drink
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
NKDA
Vorherige Impfungen
-

VAERS 2372318

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U022175

mild
Staat
FL
Alter
1,3
Geschlecht
F
Eingang
18.07.2022
Impfdatum
27.06.2022
Beginn
06.07.2022
Tage bis Beginn
9,0
Dosis
1
Route/Site
SC / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Pyrexia

Symptomtext

Pt had a low grade fever 9 days after receiving the vaccine. Lasted for 1 day.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pyrexia
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2269063

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U022175

mild
Staat
NY
Alter
1,1
Geschlecht
M
Eingang
10.05.2022
Impfdatum
25.04.2022
Beginn
09.05.2022
Tage bis Beginn
14,0
Dosis
1
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Pallor Rash Rash maculo-papular Skin lesion

Symptomtext

Pt presented on 5/9/22 with rash to torso, face, trunk, plantar surface. Started on 5/9/22 am, on trunk that spread. Not painful nor itchy. Rash blanches with pressure; maculopapular lesions with lighter halo, different sizes. No vesicular lesions.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Rash
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
Sinusitis, URI
Vorgeschichte
adenoidectomy and b/l myringotomy tubes
Andere Medikamente
None
Allergien
NKDA, NKA
Vorherige Impfungen
-

VAERS 2672180

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U022175

gering
Staat
NC
Alter
-
Geschlecht
U
Eingang
16.08.2023
Impfdatum
10.08.2023
Beginn
10.08.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

No other AE and no PQC; HBP calling to report an administration of an expired dose of MMR II was administered to a patient on 08/10/2023; This spontaneous report has been received from a "HBP" concerning a patient of unknown age and gender. The patient's concurrent conditions, medical history, concomitant therapies and drug/allergy history were not reported. On 10-AUG-2023, the patient was vaccinated with an expired dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (rHA) (M-M-R II), lot # U022175 (has been verified to be a valid lot number, expiration date reported and upon internal validation established as 14-JUL-2023) for prophylaxis (dose, anatomical location, and route of administration were not reported) (expired product administered). No symptoms or adverse events were reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2664120

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U022175

gering
Staat
SC
Alter
-
Geschlecht
U
Eingang
01.08.2023
Impfdatum
28.07.2023
Beginn
28.07.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

no symptoms reported; HCP reported inadvertent administration of expired MMR-II that was stored properly; This spontaneous report was received from a pharmacist, referring to a patient. Information regarding the patient's pertinent medical history, concurrent condition and concomitant medication was not provided. On 28-JUL-2023, the patient was inadvertently vaccinated with expired dose of measles, mumps, and rubella (Wistar RA 27-3) virus vaccine, live, rHA (M-M-R II) injection (1 dosage form, lot #U022175, expiration date 14-JUL-2023, exact dose, route of administration and anatomical location were not provided) for prophylaxis (Expired vaccine used). No symptoms reported. No additional adverse event (AE)/ product quality complaint (PQC) (No adverse event).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2663411

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U022175

gering
Staat
IL
Alter
5,0
Geschlecht
M
Eingang
31.07.2023
Impfdatum
25.07.2023
Beginn
25.07.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

No additional AE; an expired MMRII vaccine and expired DILUENT were given to a patient inadvertently; This spontaneous report was received from a registered nurse concerning a 5-year-old male patient. The patient's concurrent condition, medical history and concomitant medication were not reported. On 25-JUL-2023, the patient was inadvertently vaccinated with expired measles, mumps, and rubella (Wistar RA 27-3) virus vaccine, live (recombinant human albumin [rHA]) (M-M-R II) injection, 0.5 mL (lot #U022175, expiration date: 14-JUL-2023, route of administration and anatomical location not provided); and with expired sterile diluent solution for injection/infusion, 0.5 mL, once (lot #U002746, expiration date: 25-JUN-2023, strength, and route of administration not provided) as prophylaxis (expired product administered). Neither products had experienced a temperature excursion. No additional adverse event (AE).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2405331

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U022175

gering
Staat
CT
Alter
-
Geschlecht
U
Eingang
09.08.2022
Impfdatum
01.08.2022
Beginn
01.08.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No additional AEs/no PQCs.; HCP called in to report a temperature excursion and also reported that the vaccine, MMR- II was administered.; This spontaneous report was received from a licensed practical nurse and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions, drug reactions/allergies and concomitant therapies were not reported. On 01-AUG-2022, the patient was vaccinated with improperly stored (product storage error) dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (recombinant Human albumin) (M-M-R II) lot #: U022175, expiration date: 14-JUL-2023 (exact dose, formulation, strength, site and route of administration were not provided) for prophylaxis. There was no additional adverse event reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2405322

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U022175

gering
Staat
NY
Alter
-
Geschlecht
U
Eingang
09.08.2022
Impfdatum
13.07.2022
Beginn
13.07.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No additonal AE's; an improperly stored MMR II vaccine was administered to a patient.; This spontaneous report was received from a medical assistant and referring to a patient of unknown age and gender. The patient's pertinent medical history, concomitant medications, concurrent conditions, and previous drug reactions or allergies were not reported. On 13-JUL-2022, the patient was vaccinated with an improperly stored measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (recombinant human albumin [rHA]) (M-M-R II) subcutaneous injection, lot #U022175, expiration date: 14-JUL-2023 (strength, dose, and route of administration were not provided), used as directed to prevent measles, mumps and rubella infection. The vaccines underwent the temperature excursion of 10 degree Celsius (C) for 57 hours (Product storage error). There was no previous temperature excursions. There was no additional adverse event.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2404693

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U022175

gering
Staat
TX
Alter
15,0
Geschlecht
F
Eingang
08.08.2022
Impfdatum
01.08.2022
Beginn
01.08.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
SC / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Inappropriate schedule of product administration

Symptomtext

Patient and mother came into clinic searching for catch up vaccines required for school. Nurse reviewed vaccine record and determined that the needed vaccines included Hep B, Tdap, IPV, MMR, and Hep A. System also prompted the need for all stated vaccines and wre verified. Nurse prepared, administered and monitored patient through the visit and showed no vivibe signs or symptoms of distress. Nurse reviewed the vaccine history and realized that Hep A was given at a 4 month interval, instead of the required 6 months. Nurse made supervisor aware and called patients father 8/8/2022 to explain the situation. Father was given the oportunity to ask all questions and all were answered. Nurse recommended a later date to administer Hep A with a correct interval.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Inappropriate schedule of product administration
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 2398141

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U022175

gering
Staat
GA
Alter
5,0
Geschlecht
M
Eingang
01.08.2022
Impfdatum
30.07.2022
Beginn
30.07.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
SC / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Cyanosis Opisthotonus Unresponsive to stimuli

Symptomtext

0940 7/30/22 Patient was unresponsive, blue across bilateral upper eyes with back slightly arched. A cool compression was applied across the patient's forehead and chest. After applying cool compression patient became responsive to name and touch stimuli. administrated EpiPen 0.3mg in upper right thigh at 0942. Vital signs obtained patient legs elevated and more cool compression was applied as transport arrived. Report was given to ER Provider . Patient was taken to the ER via wheelchair with his mother holding him in her lap patient was alert and orited x3.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Cyanosis
Hospital-Tage
-
Labordaten
none started patient was transported to ER for higher level of care.
Aktuelle Erkrankungen
No known illnesses.
Vorgeschichte
None reported.
Andere Medikamente
Unknown
Allergien
No known allergies to medication.
Vorherige Impfungen
-

VAERS 2368932

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U022175

gering
Staat
MI
Alter
1,1
Geschlecht
F
Eingang
14.07.2022
Impfdatum
13.07.2022
Beginn
14.07.2022
Tage bis Beginn
1,0
Dosis
1
Route/Site
SC / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Wrong product administered

Symptomtext

Patient received Menveo instead of Acthib. MA pulled wrong vaccine.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Wrong product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2311693

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge u022175

gering
Staat
MO
Alter
-
Geschlecht
U
Eingang
07.07.2022
Impfdatum
06.06.2022
Beginn
06.06.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
SC / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No additional AEs or PQC reported; Caller reports MMR II and VARIVAX administered after reconstitution with expired sterile diluent.; Caller reports MMR II and VARIVAX administered after reconstitution with expired sterile diluent.; This spontaneous report was received from registered nurse, concerning to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 06-JUN-2022, the patient was vaccinated with varicella virus vaccine live (oka/merck) (VARIVAX) 0.5 milliliter subcutaneous, lot #T032319, expiration date: 22-SEP-2022, for prophylaxis (strength was not provided) and measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) 0.5 milliliter subcutaneous, lot #U022175, expiration date: 14-JUL-2023, for prophylaxis (strength was not provided); after reconstitution with sterile diluent 0.5 milliliter, product quantity: 2, lot #S030249, expiration date: 02-JUN-2022, administered subcutaneously (strength was not reported) (Expired product administered) (Product preparation issue). No additional adverse events were reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2311693

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U022175

gering
Staat
MO
Alter
-
Geschlecht
U
Eingang
07.07.2022
Impfdatum
06.06.2022
Beginn
06.06.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No additional AEs or PQC reported; Caller reports MMR II and VARIVAX administered after reconstitution with expired sterile diluent.; Caller reports MMR II and VARIVAX administered after reconstitution with expired sterile diluent.; This spontaneous report was received from registered nurse, concerning to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 06-JUN-2022, the patient was vaccinated with varicella virus vaccine live (oka/merck) (VARIVAX) 0.5 milliliter subcutaneous, lot #T032319, expiration date: 22-SEP-2022, for prophylaxis (strength was not provided) and measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) 0.5 milliliter subcutaneous, lot #U022175, expiration date: 14-JUL-2023, for prophylaxis (strength was not provided); after reconstitution with sterile diluent 0.5 milliliter, product quantity: 2, lot #S030249, expiration date: 02-JUN-2022, administered subcutaneously (strength was not reported) (Expired product administered) (Product preparation issue). No additional adverse events were reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-